pharmaphorum

JANUARY 5, 2023

A new operating model for pharma shifted priorities and forced companies to rethink their organisational strategies. Everything from transitioning to virtual meetings with healthcare providers, to navigating the logistics of supply chain disruptions, has permanently altered pharma operations – many would say for the better.

Pharmaceutical 88

Pharmaceutical Recruitment Training Education 88

PM360

APRIL 7, 2023

No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Pharmaceutical Representative Training

JANUARY 29, 2025

The existence of biosimilars is meant to address both the cost and access of biologics in the healthcare industry. [1] Newer or less prominent manufacturers will struggle the most with these challenges, but there are teams with the experience and tools to overcome these obstacles and get more biosimilars into the pharma market.

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Contrarian Sales Techniques

FEBRUARY 10, 2023

According to various market research reports, the global non-invasive medical devices market was valued at approximately USD 45 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of over 6% from 2021 to 2028. This growth is driven by several factors, including: 1.

Healthcare 52

Healthcare Healthcare Manufacturing Medical 52

Medico Reach

JUNE 16, 2022

The US national healthcare expenditure for 2020 was $4.1 trillion by 2028. Healthcare happens to be the 3rd largest industry in the country, with massive growth happening across the following sectors: Healthcare marketing Healthcare tech Health administration Pharmaceuticals Health insurance. billion Pharma: $169.9

Healthcare 98

Healthcare Healthcare Distribution Healthcare Provider 98

pharmaphorum

OCTOBER 10, 2022

As part of efforts to increase uptake of screening programmes, purpose-driven partnerships between the NHS and the pharma industry have emerged as an innovative solution to raise patient awareness. The goal set out by the NHSE Long Term Plan is ambitions: to have three quarters of cancers diagnosed at an early stage by 2028.

Patients 98

Patients Pharma Media Training 98